M&A Deal Summary

Meda Acquires MedPointe Pharmaceuticals

On July 20, 2007, Meda acquired life science company MedPointe Pharmaceuticals from The Carlyle Group, Ferrer Freeman, The Cypress Group and Frazier Healthcare Partners for 800M USD

Acquisition Highlights
  • This is Meda’s 3rd transaction in the Life Science sector.
  • This is Meda’s 4th largest (disclosed) transaction.
  • This is Meda’s 1st transaction in the United States.
  • This is Meda’s 1st transaction in New Jersey.

M&A Deal Summary

Date 2007-07-20
Target MedPointe Pharmaceuticals
Sector Life Science
Buyer(s) Meda
Sellers(s) The Carlyle Group
Ferrer Freeman
The Cypress Group
Frazier Healthcare Partners
Deal Type Add-on Acquisition
Deal Value 800M USD

Target

MedPointe Pharmaceuticals

Somerset, New Jersey, United States
website
MedPointe, Inc. develops, manufactures and markets a broad range of branded prescription specialty pharmaceutical products in the U.S.

Search 190,634 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Meda

Solna, Sweden

website


Category Company
Sector Life Science
Revenue 19.6B SEK (2015)
DESCRIPTION

Meda is an operator of an international specialty pharma company that is fully represented in Europe and the US through its own sales organizations in more than 50 countries. Meda’s products are sold in about 120 countries, and where it lacks a sales organization, it markets and sells its products via agents and other pharmaceutical companies. Meda has a diversified geographic footprint with approximately 62 percent of Meda's sales generated in Western Europe (the largest countries being Italy, Germany, France, and Sweden), 19 percent in Emerging Markets (driven by China, Russia, the Middle East, and Thailand) and 17 percent in the U.S. Meda has a network of seven manufacturing facilities in Europe, the U.S. and India. Meda is based in Solna, Sweden.


DEAL STATS #
Overall 3 of 7
Sector (Life Science) 3 of 6
Type (Add-on Acquisition) 3 of 7
State (New Jersey) 1 of 1
Country (United States) 1 of 3
Year (2007) 1 of 1
Size (of disclosed) 4 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-08-10 VIATRIS KG

Bad Homburg, Germany

VIATRIS develops, manufactures and distributes branded pharmaceuticals and licenses in products from other major pharmaceuticals businesses.

Buy €750M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-10-05 Alaven Pharmaceuticals

Marietta, Georgia, United States

Alaven Pharmaceutical LLC is a specialty pharmaceutical company, develops and markets prescription and non-prescription products that treat women’s health, gastroenterology, and anemia conditions in the United States.

Buy $350M

Seller(S) 4

SELLER

The Carlyle Group

Washington, District of Columbia, United States

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 1987
PE ASSETS 376.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION
Carlyle's corporate headquarters on Pennsylvania Ave. in Washington, DC.
Carlyle's corporate headquarters on Pennsylvania Ave. in Washington, DC.

The Carlyle Group is a global investment firm that pursues private equity, credit, and real estate investments worldwide. Carlyle's private equity practice practice pursues buyouts, strategic minority equity investments, equity private placements, consolidations and buildups, and growth capital financings. With offices in 19 countries, Carlyle can easily target opportunities throughout North America, Europe, Asia, Australia, the Middle East/North Africa and Latin America. Broad sectors of interest include aerospace, defense, automotive and transportation, consumer, retail, energy and power, financial services, healthcare, industrial, infrastructure, technology services, business services, telecommunications and media. The Carlyle Group was formed in 1987 and is based in Washington DC.


DEAL STATS #
Overall 99 of 442
Sector (Life Science) 3 of 8
Type (Add-on Acquisition) 50 of 184
State (New Jersey) 2 of 8
Country (United States) 67 of 250
Year (2007) 13 of 24
Size (of disclosed) 39 of 130
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-07-19 SemGroup

Tulsa, Oklahoma, United States

SemGroup Corp. moves energy across North America through a network of pipelines, processing plants, refinery-connected storage facilities and deep-water marine terminals with import and export capabilities. SemGroup serves as a versatile connection between upstream oil and gas producers and downstream refiners and end-users. Key areas of operation and growth include western Canada, the Mid-Continent and the Gulf Coast. SemGroup is committed to safe, environmentally sound operations. Headquartered in Tulsa, Okla., the company has additional offices in Calgary, Alberta; Denver, Colo.; and Houston, Texas. SemGroup uses its Investor Relations website and social media outlets as channels of distribution of material company information. SemGroup Corporation was founded in 2000 and is headquartered in Tulsa, Oklahoma.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-07-23 Applus+

Madrid, Spain

Applus+ is a global certification company specializing in testing, inspection, certification, and technological services. Applus+ was incorporated in 1996 and is based in Madrid, Spain.

Buy €1.5B
SELLER

Ferrer Freeman

Greenwich, Connecticut, United States

website


Category Private Equity Firm
Founded 1995
PE ASSETS 900M USD
Size Middle-Market
Type Sector Focused
DESCRIPTION

Ferrer Freeman & Co. (FFC) is a private equity firm that invests exclusively in healthcare companies generating sales minimum $20 to $200 million. FFC also invests in clinical products and outsourcing/infrastructure businesses serving the healthcare sector. FFC looks to commit $10 to $40 million per transaction and focuses primarily on growth capital financings and build-ups. However, the Firm will also selectively fund buyouts as well. Ferrer Freeman & Co. LLC was formed in 1995 and is based in Greenwich, Connecticut.


DEAL STATS #
Overall 7 of 23
Sector (Life Science) 3 of 4
Type (Add-on Acquisition) 6 of 15
State (New Jersey) 1 of 2
Country (United States) 7 of 23
Year (2007) 2 of 2
Size (of disclosed) 4 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-05-31 Activus Healthcare Solutions

Westlake Village, California, United States

Activus Healthcare Solutions is a distributor of medical and surgical products to alternate site clinics and physician offices.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-12-01 Reliant Renal Care

Media, Pennsylvania, United States

Reliant Renal Care, Inc. is a dialysis build-up that develops and acquires outpatient dialysis facilities to serve patients with end stage renal disease.

Buy $50M
SELLER

The Cypress Group

New York, New York, United States

website


Category Private Equity Firm
Founded 1989
PE ASSETS 4.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

The Cypress Group is a private equity firm that acquires businesses in a range of industries. Broad sectors of interest include consumer services, financial services, and manufacturing. The Cypress Group was formed in 1989 and is headquartered in New York, New York.


DEAL STATS #
Overall 7 of 12
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 3
State (New Jersey) 1 of 1
Country (United States) 5 of 10
Year (2007) 2 of 3
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-04-24 Cinemark

Plano, Texas, United States

Cinemark is an operator of movie theaters in the United States, or U.S., Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Cinemark was incorporated in 1984 and is based in Plano, Texas.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-12-07 ClubCorp Holdings

Dallas, Texas, United States

ClubCorp Holdings owns and operates golf, country, business, sports, and alumni clubs. ClubCorp owns or operates a portfolio of over 200 golf and country clubs, business clubs, sports clubs, and alumni clubs in 28 states, the District of Columbia and two foreign countries that serve over 430,000 members, with approximately 20,000 peak-season employees. ClubCorp Holdings was founded in 1957 and is based in Dallas, Texas.

Sell -
SELLER
DESCRIPTION

Frazier Healthcare Partners is a private equity and venture capital firm specializing in Growth buyout investment specifically targets businesses that deal Healthcare, Life Sciences, Pharmaceutical services, medical products, and related sectors. Frazier Healthcare Partners was formed in 1991 and is based in Seattle, Washington with an additional office in Palo Alto, California; Boston, Massachusetts; and Menlo Park, California.


DEAL STATS #
Overall 4 of 26
Sector (Life Science) 1 of 9
Type (Add-on Acquisition) 3 of 12
State (New Jersey) 1 of 2
Country (United States) 4 of 26
Year (2007) 2 of 3
Size (of disclosed) 3 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-06-01 ppoNEXT

Long Beach, California, United States

ppoNEXT is a holding company formed to consolidate the Preferred Provider Organization (PPO) industry. PPOs provide members with access to a broad network of health care providers at substantial discounts to the usual fees.

Sell $19M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-08-01 Bravo Health

Baltimore, Maryland, United States

Bravo Health’s licensed subsidiaries provide Medicare beneficiaries access to high quality, cost-effective health care. With more than 390,000 members, Bravo Health’s licensed subsidiaries offer Medicare Advantage health plans in Delaware, Maryland, New Jersey, Pennsylvania, Texas and Washington, D.C. and offer Part D Prescription Drug Plans in 43 states.

Buy -